story of the week
Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
J. Clin. Oncol 2021 Apr 30;[EPub Ahead of Print], ST Tagawa, AV Balar, DP Petrylak, AR Kalebasty, Y Loriot, A Fléchon, RK Jain, N Agarwal, M Bupathi, P Barthelemy, P Beuzeboc, P Palmbos, CE Kyriakopoulos, D Pouessel, CN Sternberg, Q Hong, T Goswami, LM Itri, P GrivasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.